Everyone, good morning, and thank you for joining us for our Fifth Annual TD Cowen Novel Mechanisms in Neuropsychiatry and Epilepsy Summit. I'm Joe Thome, one of the senior biotech analysts here on the team at TD Cowen, and it is my pleasure to kick things off this morning with the team from Axsome Therapeutics. And joining me today, we have COO, Mark Jacobson; and CFO, Nick Pizzie. So thanks, guys, for joining us this morning.Question-and-Answer Session Joseph ThomeTD Cowen, Research Division Maybe just a ...